Global Adult and Adolescent Vaccines Market Size By Product Type (Seasonal Vaccines and Travel Vaccines), By Application (Adult and Adolescent), By Geography Scope And Forecast
Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Adult and Adolescent Vaccines Market Size By Product Type (Seasonal Vaccines and Travel Vaccines), By Application (Adult and Adolescent), By Geography Scope And Forecast
Adult and Adolescent Vaccines Market Size And Forecast
Adult and Adolescent Vaccines Market size was valued at USD 22.33 Billion in 2023 and is projected to reach USD 42 Billion by 2031, at a CAGR of 8.15% from 2024 to 2031.
Global Adult and Adolescent Vaccines Market Drivers
The market drivers for the Adult and Adolescent Vaccines Market can be influenced by various factors. These may include
- Government Initiatives and Growing knowledge The market is growing as a result of government initiatives supporting vaccination programs and rising knowledge of the value of vaccination in avoiding disease. A big part is played by efforts to inform the public and medical professionals about the advantages of vaccinations.
- Increasing Immunization Programs To address public health issues, governments and international organizations are increasing vaccination programs, particularly in developing nations. The need for adult and adolescent vaccinations is increased by this expansion.
- Growing Illness Burden The need for vaccinations is driven by the rise in infectious disease prevalence and the introduction of novel pathogens. Significant health hazards are still associated with diseases such the flu, hepatitis, meningococcal infections, and human papillomavirus (HPV), especially in adults and adolescents.
- Technological developments The market for adult and adolescent vaccines is growing as a result of developments in vaccine technology, such as the creation of novel adjuvants and delivery methods. These developments enhance the safety, effectiveness, and convenience of administration of vaccines.
- Aging Population Vaccines against age-related illnesses like influenza, pneumococcal infections, and shingles are in high demand due to the world’s ageing population. Immunization is essential for lowering healthcare expenses related to disease complications and shielding senior citizens from diseases that can be prevented by vaccination.
- Emphasis on Preventive Healthcare One of the main factors driving market expansion is the growing emphasis on vaccination and other preventive healthcare measures as a way to lower healthcare costs and enhance public health outcomes. Vaccination is acknowledged as an economical approach to avert infectious diseases and lessen the strain on medical systems.
- Globalization and Travel As a result of increased worldwide travel and globalization, infectious diseases are more likely to spread internationally. This pattern fuels the need for vaccinations to shield tourists against illnesses like Japanese encephalitis, typhoid, and yellow fever that are common in many parts of the world.
- Economic Development Growing disposable incomes and economic development in developing nations drive up the cost of healthcare, including vaccinations. Increased affordability of vaccinations due to growing economies propels market expansion.
- Regulatory Support Innovation and market entry are stimulated by favourable regulatory rules and accelerated vaccine approval procedures, which promote competition and propel market expansion.
- Pandemic Preparedness The significance of vaccination in pandemic preparedness and response activities has been brought to light by recent pandemics, including the COVID-19 pandemic. Dealing with such health emergencies highlights the necessity of strong immunization programs, which should include the creation and administration of adult and adolescent vaccines.
What's inside a
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
What's inside a
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Adult and Adolescent Vaccines Market Restraints
Several factors can act as restraints or challenges for the Adult and Adolescent Vaccines Market. These may include
- Vaccine hesitation Misinformation, mistrust, and safety concerns are the main causes of vaccine hesitation, which makes immunization campaigns extremely difficult. Certain demographic segments’ skepticism over the safety and efficacy of vaccines can reduce vaccination rates, which will have an effect on market expansion.
- High Development expenses Vaccine makers find it difficult to enter the market due to the high expenses involved in vaccine research, development, and clinical trials. Companies may be discouraged from investing in the development of novel vaccines due to the high costs associated with vaccine research and the unpredictability of the results.
- Supply Chain Challenges Ensuring a sufficient and reliable supply of vaccinations worldwide is hampered by complicated vaccine manufacturing procedures and logistics of delivery. Disruptions to the supply chain, like the ones that occurred during the COVID-19 pandemic, might affect the stability of the market and result in vaccine shortages.
- Regulatory Obstacles Tight regulations pertaining to vaccine approval and licensing can cause delays in the market’s entry and raise development expenses for producers. Complying with various regulatory frameworks in various locations complicates the process of developing and approving vaccines.
- Limited Accessibility and Affordability Immunization efforts are hampered by inadequate access to vaccines, especially in low-income and rural areas. This is because of challenges with infrastructure, inefficiencies in the supply chain, and affordability. Inequalities in vaccine access impede market expansion and are a contributing factor to healthcare disparities.
- The creation of vaccinations against certain diseases, such HIV/AIDS and tuberculosis, poses scientific and technical obstacles that impede the pace of vaccine research and development. The market potential in these domains are restricted by the intricate nature of these illnesses and the dearth of viable vaccine candidates.
- Safety Concerns and Adverse Events Even infrequent reports of side effects from vaccinations can damage public confidence in the shots and reduce demand. Resolving safety issues and preserving open lines of communication regarding the safety of vaccines are crucial for reducing these dangers.
- Competition from Generic Products The availability of biosimilars and generic vaccinations, especially in developing nations, increases competition and drives down prices. Manufacturers of vaccines may find their market share and profitability restricted by this competitive environment.
- Litigation and Vaccine Liability Risks The financial and legal risks connected to the production and distribution of vaccines might be exacerbated by worries about vaccine liability and the possibility of litigation resulting from unfavorable outcomes. In the case that there are safety-related issues, vaccine makers may have to pay legal fees and risk harm to their brand.
- Political and Socioeconomic circumstances In some areas, political unrest, armed conflict, and socioeconomic circumstances can cause disruptions to the healthcare system and make immunization campaigns more difficult. Improving vaccination uptake and accessibility in impacted communities requires addressing these fundamental issues.
Global Adult and Adolescent Vaccines Market Segmentation Analysis
The Global Adult and Adolescent Vaccines Market is segmented based on Product Type, Application, and Geography.
Adult and Adolescent Vaccines Market, By Product Type
- Seasonal Vaccines
- Travel Vaccines
Based on the Product Type, the market is segmented into Seasonal Vaccines and Travel Vaccines. Vaccines for travel are those that offer defense against illnesses that are widespread elsewhere in the world. They consist of shots for typhoid, yellow fever, rabies, meningococcal illness, and hepatitis A and B vaccinations. People who are traveling to particular nations or regions where certain diseases are more prevalent are advised to get travel immunizations.
Adult and Adolescent Vaccines Market, By Application
- Adult
- Adolescent
Based on the Application, the market is segmented into Adult and Adolescent. The importance of vaccinations in preventing disease cannot be overstated. Many adults erroneously think that only young children require vaccinations, but this is untrue. Adults also need vaccinations. Some individuals need particular vaccinations in order to keep healthy and avoid getting sick since they are more susceptible to certain diseases.
Adult and Adolescent Vaccines Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Based on Geography, the Adult and Adolescent Vaccines Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America holds the largest market share due to the increasing use of vaccines in adults and adolescents.
Key Players
The “Adult and Adolescent Vaccines Market” study report will provide valuable insight with an emphasis on the global market. GlaxoSmithKline plc, Sanofi, Pfizer, MERCK & CO., INC., Novartis AG, CSL Limited, AstraZeneca, Sinovac Biotech Ltd., Serum Institute of India Pvt. Ltd., and Hualan Biological Engineering Inc., and others are prominent manufacturers operating in the market.
Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2020-2031 |
BASE YEAR | 2023 |
FORECAST PERIOD | 2024-2031 |
HISTORICAL PERIOD | 2020-2022 |
UNIT | Value (USD Billion) |
KEY COMPANIES PROFILED | GlaxoSmithKline plc, Sanofi, Pfizer, MERCK & CO., INC., Novartis AG, CSL Limited, AstraZeneca, Sinovac Biotech Ltd., Serum Institute of India Pvt. Ltd., and Hualan Biological Engineering Inc., and others |
SEGMENTS COVERED |
|
CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.